Effective treatment of a platinum‑resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition
- 21 May 2018
- journal article
- research article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 9 (1) , 30-34
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common type of non‑melanoma skin cancer. Platinum‑based regimens have been an integral part of palliative care for patients with locally advanced or metastatic disease. There is no evidence of efficacy for later lines of chemotherapy and no targeted therapy has been introduced as ‘standard of care’. Here we report on the case of an elderly cSCC patient, resistant to conventional therapy, however successfully treated with anti‑epidermal growth factor receptor (EGFR) agent (Cetuximab) in addition to a daily dose of Curcumin phospholipid. The patient responded to treatment and experienced no recurrence for 11 months with only minor skin‑related toxicity. To our knowledge, this is the first report of clinical evidence that an anti EGFR targeted therapy with a daily oral dose of Curcumin phospholipid is well tolerated and results in a highly effective disease control in a heavily pretreated cSCC patient.Keywords
This publication has 30 references indexed in Scilit:
- Cutaneous squamous cell carcinoma: an epidemiological reviewBritish Journal of Dermatology, 2017
- Management of Skin Cancer in the High-Risk PatientCurrent Treatment Options in Oncology, 2016
- Molecular targets of curcumin for cancer therapy: an updated reviewTumor Biology, 2016
- Evaluation of 122 advanced‐stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesCancer, 2015
- Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancerClinical Biochemistry, 2015
- A novel mutation Ser344Cys in FGFR3 causes achondroplasia with severe platyspondylyAmerican Journal of Medical Genetics Part A, 2015
- Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor typesCell Cycle, 2015
- Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In VivoScientific Reports, 2015
- EGFR Inhibition by Curcumin in Cancer Cells: A Dual Mode of ActionBiomacromolecules, 2015
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical UseCold Spring Harbor Perspectives in Biology, 2009